Acloproxalap

N/A

Report date: 2024/06/21 15:50:40
NME

Base Information

Drug NameAcloproxalap
Drug Alias NameADX-629
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReactive Aldehyde Species modulators
TargetsReactive Aldehyde Species
Therapy Area/IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Allergic asthma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAldeyra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAldeyra Therapeutics IncUniversity of Nebraska
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Allergic asthma +[7] 
Inactive IndicationsNephrotic Syndrome

Other Information

ATC CodeN/A
Related LinksN/A